Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Acad Radiol. 2019 Dec 13;27(8):e204–e215. doi: 10.1016/j.acra.2019.10.030

Table 4.

Differences in radiomic values between control and sarcoidosis subjects by lobe. Negative values indicate lower average radiomic values in the healthy controls as compared to the sarcoidosis population. Results are presented as mean (95% CI). P-values indicate whether the group effect changed significantly across lobes, with significant results bolded.

Outcome Left Upper Lobe Left Lower Lobe Right Upper Lobe Right Middle Lobe Right Lower Lobe P-value
Mean −11.39 (−19.66, −3.12) −11.08 (−19.35, −2.81) −12.53 (−20.80, −4.26) −7.10 (−15.37, 1.18) −10.55 (−18.82, −2.28) 0.3943
SD −15.58 (−20.08, −11.09) −9.14 (−13.64, −4.65) −17.03 (−21.52, −12.53) −13.45 (−17.95, −8.96) −11.38 (−15.87, −6.88) <0.0001
Skew 0.63 (0.46, 0.79) 0.42 (0.26, 0.59) 0.64 (0.48, 0.81) 0.60 (0.44, 0.77) 0.49 (0.32, 0.65) 0.0002
Kurtosis 6.67 (5.19, 8.15) 3.90 (2.41, 5.38) 6.62 (5.14, 8.11) 6.64 (5.15, 8.12) 4.95 (3.46, 6.43) <0.0001
Contrast 1.06 (0.30, 1.83) 0.69 (−0.07, 1.46) 0.91 (0.15, 1.68) 1.41 (0.64, 2.18) 0.79 (0.03, 1.56) 0.0105
Autocorrelation −0.87 (−1.26, −0.48) −0.61 (−1.00, −0.22) −0.74 (−1.13, −0.35) −0.97 (−1.36, −0.58) −0.62 (−1.01, −0.23) 0.0086
Energy (x1000) −0.44 (−0.67, −0.20) −0.25 (−0.49, −0.01) −0.39 (−0.62, −0.15) −0.43 (−0.66, −0.19) −0.32 (−0.55, −0.08) 0.0873
Homogeneity (x100) −1.01 (−1.76, −0.26) −0.60 (−1.35, 0.15) −0.83 (−1.58, −0.08) −1.22 (−1.97, −0.47) −0.72 (−1.47, 0.03) 0.0559